scispace - formally typeset
R

Rong-li Lu

Researcher at Central South University

Publications -  13
Citations -  66

Rong-li Lu is an academic researcher from Central South University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 31 citations.

Papers
More filters
Journal ArticleDOI

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

TL;DR: The EGFR mutation was significantly associated with well-differentiated tumor and excessive household cooking fumes LAC, and the deletions in exon 19 may benefit more from first-line targeted therapy of advanced LAC compared with exon 21 point mutation L858R.
Journal ArticleDOI

High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial

TL;DR: In this paper , a randomized controlled trial was conducted from July 2017 to December 2020 in 16 tertiary hospitals in China, where patients with acute COPD exacerbation with mild hypercapnia (pH ≥ 7.35 and arterial partial pressure of carbon dioxide > 45 mmHg) were randomly assigned to either HFNC or conventional oxygen therapy.
Journal ArticleDOI

Expression of High Mobility GroupA2 is Associated with Poor Survival in Hepatocellular Carcinoma

TL;DR: HMGA2 expression in HCC is investigated to determine its clinicopathologic and prognostic value and studies suggest that HMGA2 protein overexpression may lead to neoplastic transformation.
Journal ArticleDOI

MiR-29a-3p Improves Acute Lung Injury by Reducing Alveolar Epithelial Cell PANoptosis

TL;DR: It is found that miR-29a-3p was down-regulated in plasma of ARDS patients and lung tissue of ALI model mice, and agomir injection down- regulated the levels of the inflammatory factors, ultimately improving lung injury in the ALi model mice.
Journal ArticleDOI

A Clinically Applicable Nomogram for Predicting the Risk of Invasive Mechanical Ventilation in Pneumocystis jirovecii Pneumonia

TL;DR: Clinical application of this model enables early identification of patients with PCP who require IMV, which, in turn, may lead to rational therapeutic choices and improved clinical outcomes.